prodisc C Nova
Centinel Spine, LLC · Decision date Sep 9, 2026
What did the FDA approve?
FDA records P070001/S031 as a supplement to PMA P070001, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Sep 9, 2026.
FDA approval order statement
The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) has completed its review of your premarket approval application (PMA) 180-day supplement, which requested approval for the prodisc C Nova requesting expansion of the indications from one-level use to two-level use.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track
- Clinical specialty
- Orthopedic
- Decision date
- Sep 9, 2026
- FDA change category
- Labeling Change - Indications/instructions/shelf life/tradename
Regulatory record facts
- Identifier
- P070001/S031
- Regulatory pathway
- PMA supplement
- Applicant
- Centinel Spine, LLC
- Product code
- MJO
- Decision code
- APPR
- Decision date
- Sep 9, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Prosthesis, intervertebral disc.
- Applicant
- Centinel Spine, LLC
- Product code
- MJO
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P070001. Subsequent supplements may change the device or its indications.
FDA decision timeline
P070001 · Original PMA
PRODISC TM-C TOTAL DISC REPLACEMENT
P070001/S031 received
Application receipt date recorded by FDA.
P070001/S031 · FDA decision
Normal 180 Day Track
Timeline entries are records held by MedtechLedger for P070001. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P070001
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Centinel Spine, LLC | PMA approval | Dec 17, 2007 | FDA |
Explore the linked device profile
Other records with product code MJO
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BAGUERAC Cervical Disc ProsthesisP250042/S002 | Spineart USA, Inc. | PMA supplement | Sep 22, 2026 | FDA |
Synergy DiscP250028/S003 | Synergy Spine Solutions, Inc. | PMA supplement | Sep 17, 2026 | FDA |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
| Highridge Medical, LLC | PMA supplement | Sep 16, 2026 | FDA | |
| Spineart USA, Inc. | PMA approval | Aug 10, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Centinel Spine, LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 900 Airport Rd., Suite 3b, West Chester, PA, 19380
Sources and methodology
- Original FDA record: P070001/S031
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records



